Interestingly, CD44 has also been identified as a cancer stem cell (CSC) marker in PCa; CD44-positive cells are more proliferative, clonogenic, tumorigenic, and metastatic than isogenic CD44-negative cells [30,31,32]. The gene discussed is CD44; the disease is posterior cortical atrophy.